{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T15:00:12Z","timestamp":1764687612520},"reference-count":88,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[1987,10,1]],"date-time":"1987-10-01T00:00:00Z","timestamp":560044800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medical Toxicology"],"published-print":{"date-parts":[[1987,10]]},"DOI":"10.1007\/bf03259952","type":"journal-article","created":{"date-parts":[[2012,11,29]],"date-time":"2012-11-29T10:26:54Z","timestamp":1354184814000},"page":"324-337","source":"Crossref","is-referenced-by-count":7,"title":["The Risk-Benefit Ratio of Anticonvulsant Drugs"],"prefix":"10.1007","volume":"2","author":[{"given":"M. J.","family":"Eadie","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,11,28]]},"reference":[{"key":"BF03259952_CR1","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1001\/archneur.1976.00500040080014","volume":"33","author":"JA Aarli","year":"1976","unstructured":"Aarli JA. Drug-induced IgA deficiency in epileptic patients. Archives of Neurology 33: 296\u2013299, 1976","journal-title":"Archives of Neurology"},{"key":"BF03259952_CR2","first-page":"261","volume-title":"Chronic toxicity of antiepileptic drugs","author":"JA Aarli","year":"1983","unstructured":"Aarli JA, Gilhus NE. Antiepileptic drugs and resistance to infections. In Oxley et al. (Eds) Chronic toxicity of antiepileptic drugs, pp. 261\u2013267, Raven Press, New York, 1983"},{"key":"BF03259952_CR3","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/S0140-6736(75)92153-4","volume":"2","author":"D Aarskog","year":"1975","unstructured":"Aarskog D. Association between maternal intake of diazepam and oral clefts. Lancet 2: 921, 1975","journal-title":"Lancet"},{"key":"BF03259952_CR4","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1159\/000180836","volume":"18","author":"BN Agarwal","year":"1977","unstructured":"Agarwal BN, Cabebe FG, Hoffman BI. Diphenylhydantoin induced acute renal failure. Nephron 18: 249\u2013251, 1977","journal-title":"Nephron"},{"key":"BF03259952_CR5","first-page":"71","volume":"4","author":"E Albengres","year":"1983","unstructured":"Albengres E, Tillement JP. Phenytoin in pregnancy: a review of the reported risks. Biological Research in Pregnancy 4: 71\u201374, 1983","journal-title":"Biological Research in Pregnancy"},{"key":"BF03259952_CR6","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1600-0404.1984.tb05665.x","volume":"99","author":"DG Andrewes","year":"1984","unstructured":"Andrewes DG, Tomlinson L, Elwes RDC, Reynolds EH. The influence of carbamazepine and phenytoin on memory and other aspects of cognitive function in new referrals with epilepsy. Acta Neurologica Scandinavica 99 (Suppl.): 23\u201330, 1984","journal-title":"Acta Neurologica Scandinavica"},{"key":"BF03259952_CR7","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/0030-4220(72)90228-9","volume":"34","author":"AP Angelopoulos","year":"1972","unstructured":"Angelopoulos AP, Goaz PW. Incidence of diphenylhydantoin gingival hyperplasia. Oral Surgery 34: 898\u2013906, 1972","journal-title":"Oral Surgery"},{"key":"BF03259952_CR8","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1001\/archneur.1974.00490420030002","volume":"31","author":"JF Annegers","year":"1974","unstructured":"Annegers JF, Elveback LR, Hauser WA, Kurland LT. Do anti-convulsants have a teratogenic effect? Archives of Neurology 31: 364\u2013373, 1974","journal-title":"Archives of Neurology"},{"key":"BF03259952_CR9","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0022-3476(73)80027-7","volume":"82","author":"DH Beernink","year":"1973","unstructured":"Beernink DH, MillerIII JJ. Anticonvulsant induced antinuclear antibodies and lupus like disease in children. Journal of Pediatrics 82: 113\u2013117, 1973","journal-title":"Journal of Pediatrics"},{"key":"BF03259952_CR10","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2165\/00003495-198631030-00003","volume":"31","author":"E Beghi","year":"1986","unstructured":"Beghi E, DiMasus R, Tognoni G. Drug treatment of epilepsy: outlines, criticism and perspectives. Drugs 31: 249\u2013265, 1986","journal-title":"Drugs"},{"key":"BF03259952_CR11","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/S0140-6736(82)90018-6","volume":"2","author":"T Bjerkedal","year":"1982","unstructured":"Bjerkedal T. Czeizerl A, Goujard J, Kallen B, Mastroiacova P, et al. Valproic acid and spina bifida. Lancet 2: 1096, 1982","journal-title":"Lancet"},{"key":"BF03259952_CR12","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1212\/WNL.31.2.194","volume":"31","author":"JB Bodensteiner","year":"1981","unstructured":"Bodensteiner JB, Morris HH, Golden GS. Asterixis associated with sodium valproate. Neurology 31: 194\u2013195, 1981","journal-title":"Neurology"},{"key":"BF03259952_CR13","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1136\/jnnp.39.12.1210","volume":"39","author":"D Chadwick","year":"1976","unstructured":"Chadwick D, Reynolds EH, Marsden CD. Anticonvulsant-induced dyskinesias: a comparison with dyskinesias induced by neuroleptics. Journal of Neurology, Neurosurgery and Psychiatry 39: 1210\u20131218, 1976","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"key":"BF03259952_CR14","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0022-3476(81)80489-1","volume":"99","author":"DL Coulter","year":"1981","unstructured":"Coulter DL, Allen RJ. Hyperammonemia with valproic acid therapy. Journal of Pediatrics 99: 317\u2013319, 1981","journal-title":"Journal of Pediatrics"},{"key":"BF03259952_CR15","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/S0140-6736(80)91773-0","volume":"1","author":"DL Coulter","year":"1980","unstructured":"Coulter DL, Allen RJ. Secondary hyperammonaemia: a possible mechanism for valproate encephalopathy. Lancet 1: 1310\u20131311, 1980","journal-title":"Lancet"},{"key":"BF03259952_CR16","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/S0022-3476(74)80372-0","volume":"85","author":"DM Danks","year":"1974","unstructured":"Danks DM, Barry JE, Sheffield LJ. Digital hypoplasia and anti-convulsants during pregnancy. Journal of Pediatrics 85: 877, 1974","journal-title":"Journal of Pediatrics"},{"key":"BF03259952_CR17","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1136\/bmj.4.5727.69","volume":"4","author":"CE Dent","year":"1970","unstructured":"Dent CE, Richens A, Rowe DJF, Stamp TCB. Osteomalacia with long-term anticonvulsant therapy. British Medical Journal 4: 69\u201372, 1970","journal-title":"British Medical Journal"},{"key":"BF03259952_CR18","first-page":"699","volume":"19","author":"GWK Donaldson","year":"1965","unstructured":"Donaldson GWK, Graham JG. Aplastic anaemia following the administration of Tegretol. British Journal of Clinical Practice 19: 699\u2013702, 1965","journal-title":"British Journal of Clinical Practice"},{"key":"BF03259952_CR19","doi-asserted-by":"crossref","first-page":"328","DOI":"10.2165\/00003495-198427040-00003","volume":"27","author":"MJ Eadie","year":"1984","unstructured":"Eadie MJ. Anticonvulsant drugs: an update. Drugs 27: 328\u2013363, 1984","journal-title":"Drugs"},{"key":"BF03259952_CR20","first-page":"129","volume-title":"The treatment of epilepsy","author":"MJ Eadie","year":"1980","unstructured":"Eadie MJ. Unwanted effects of anticonvulsant drugs. In Tyrer JH (Ed.) The treatment of epilepsy, pp. 129\u2013160, MTP Press, Lancaster, 1980"},{"key":"BF03259952_CR21","volume-title":"Anticonvulsant therapy: pharmacological basis and practice","author":"MJ Eadie","year":"1980","unstructured":"Eadie MJ, Tyrer JH. Anticonvulsant therapy: pharmacological basis and practice, 2nd ed., Churchill-Livingstone, Edinburgh, 1980","edition":"2nd"},{"key":"BF03259952_CR22","first-page":"394","volume":"7","author":"MA Falconer","year":"1974","unstructured":"Falconer MA, Davidson S. Coarse features in epilepsy as a consequence of anticonvulsant therapy. Drugs 7: 394\u2013395, 1974","journal-title":"Drugs"},{"key":"BF03259952_CR23","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.1528-1157.1978.tb04498.x","volume":"19","author":"H Fichsel","year":"1978","unstructured":"Fichsel H, Knopfle G. Effects of anticonvulsant drugs on thyroid hormone in epileptic children. Epilepsia 19: 323\u2013336, 1978","journal-title":"Epilepsia"},{"key":"BF03259952_CR24","volume-title":"Antiepileptic drugs","year":"1985","unstructured":"Frey HH, Janz D (Eds). Antiepileptic drugs, Springer, Berlin, 1985"},{"key":"BF03259952_CR25","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1111\/j.1528-1157.1984.tb03451.x","volume":"25","author":"C Geraldini","year":"1984","unstructured":"Geraldini C, Faedda MT, Sideri G. Anticonvulsant therapy and its possible consequences on peripheral nervous system. Epilepsia 25: 502\u2013505, 1984","journal-title":"Epilepsia"},{"key":"BF03259952_CR26","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1159\/000115493","volume":"21","author":"NE Gilhus","year":"1982","unstructured":"Gilhus NE, Strandjord RE, Aarli JA. Respiratory disease in patients with epilepsy on single-drug therapy with carbamazepine or phenobarbital. European Neurology 21: 284\u2013288, 1982","journal-title":"European Neurology"},{"key":"BF03259952_CR27","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2337\/diab.18.2.101","volume":"18","author":"EM Goldberg","year":"1969","unstructured":"Goldberg EM, Sandbar SS. Hyperglycemic, non-ketotic coma following administration of Dilantin (diphenylhydantoin). Diabetes 18: 101\u2013106, 1969","journal-title":"Diabetes"},{"issue":"97","key":"BF03259952_CR28","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1600-0404.1983.tb01537.x","volume":"68","author":"L Gram","year":"1983","unstructured":"Gram L, Bentsen KD. Hepatic toxicity of antiepileptic drugs: a review. Acta Neurologica Scandinavica 68 (Suppl. 97): 81\u201390, 1983","journal-title":"Acta Neurologica Scandinavica"},{"key":"BF03259952_CR29","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1136\/bmj.2.6099.1384","volume":"2","author":"JE Hegarty","year":"1977","unstructured":"Hegarty JE, Dundee JW. Sequelae after intravenous injection of three benzodiazepines \u2014 diazepam, lorazepam and flunitrazepam. British Medical Journal 2: 1384\u20131385, 1977","journal-title":"British Medical Journal"},{"key":"BF03259952_CR30","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1136\/bmj.4.5781.202","volume":"4","author":"J Hunter","year":"1971","unstructured":"Hunter J, Maxwell JD, Stewart DA, Parsons V, Williams R. Altered calcium metabolism in epileptic children on anticonvulsants. British Medical Journal 4: 202\u2013204, 1971","journal-title":"British Medical Journal"},{"key":"BF03259952_CR31","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1212\/WNL.29.8.1177","volume":"29","author":"NM Hyman","year":"1979","unstructured":"Hyman NM, Dennis PD, Sinclair KGA. Tremor due to sodium valproate. Neurology 29: 1177\u20131180, 1979","journal-title":"Neurology"},{"key":"BF03259952_CR32","first-page":"372","volume":"1","author":"F Inoue","year":"1982","unstructured":"Inoue F. Clinical implications of anticonvulsant-induced folate deficiency. Clinical Pharmacy 1: 372\u2013373, 1982","journal-title":"Clinical Pharmacy"},{"key":"BF03259952_CR33","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.1528-1157.1975.tb04732.x","volume":"16","author":"D Janz","year":"1975","unstructured":"Janz D. The teratogenic risk of antiepileptic drugs. Epilepsia 16: 159\u2013169, 1975","journal-title":"Epilepsia"},{"key":"BF03259952_CR34","first-page":"155","volume-title":"Chronic toxicity of antiepileptic drugs","author":"D Janz","year":"1983","unstructured":"Janz D, Piltz U. Frozen shoulder induced by primidone. In Oxley et al. (Eds) Chronic toxicity of antiepileptic drugs, pp. 155\u2013159, Raven Press, New York, 1983"},{"key":"BF03259952_CR35","first-page":"1","volume-title":"Chronic toxicity of antiepileptic drugs","author":"PM Jeavons","year":"1983","unstructured":"Jeavons PM. Hepatotoxicity of antiepileptic drugs. In Oxley et al. (Eds). Chronic toxicity of antiepileptic drugs, pp. 1\u201345, Raven Press, New York, 1983"},{"key":"BF03259952_CR36","first-page":"1282","volume":"2","author":"PM Jeavons","year":"1982","unstructured":"Jeavons PM. Sodium valproate and neural tube defects. Lancet 2: 1282\u20131283, 1982","journal-title":"Lancet"},{"key":"BF03259952_CR37","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/j.1469-8749.1973.tb05070.x","volume":"15","author":"RN Kapur","year":"1973","unstructured":"Kapur RN, Girgis S, Little TM, Masotti RE. Diphenylhydantoin-induced gingival hyperplasia: its relationship to dose and serum level. Developmental Medicine and Child Neurology 15: 483\u2013487, 1973","journal-title":"Developmental Medicine and Child Neurology"},{"key":"BF03259952_CR38","doi-asserted-by":"crossref","first-page":"52","DOI":"10.2214\/ajr.124.1.52","volume":"124","author":"KR Kattan","year":"1975","unstructured":"Kattan KR. Thickening of the heel pad associated with long term dilantin therapy. American Journal of Roentgenology 124: 52\u201356, 1975","journal-title":"American Journal of Roentgenology"},{"key":"BF03259952_CR39","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1001\/jama.1969.03160390032006","volume":"210","author":"JJ Kuiper","year":"1969","unstructured":"Kuiper JJ. Lymphocytic thyroiditis possibly induced by diphenylhydantoin. Journal of the American Medical Association 210: 2370\u20132372, 1969","journal-title":"Journal of the American Medical Association"},{"key":"BF03259952_CR40","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/00005053-196104000-00009","volume":"132","author":"JF Kurtzke","year":"1961","unstructured":"Kurtzke JF. Leukopenia with diphenylhydantoin. Journal of Nervous and Mental Diseases 132: 339\u2013343, 1961","journal-title":"Journal of Nervous and Mental Diseases"},{"issue":"2","key":"BF03259952_CR41","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/j.1528-1157.1984.tb05644.x","volume":"25","author":"H Kutt","year":"1984","unstructured":"Kutt H. Interactions between anticonvulsants and other commonly prescribed drugs. Epilepsia 25 (Suppl. 2): 118\u2013131, 1984","journal-title":"Epilepsia"},{"key":"BF03259952_CR42","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/S0140-6736(83)91850-0","volume":"1","author":"AACY Laiwah","year":"1983","unstructured":"Laiwah AACY, Rapeport WG, Thompson GG, MacPhee GJA, Philip MF, et al. Carbamazepine-induced non-hereditary acute porphyria. Lancet 1: 790\u2013792, 1983","journal-title":"Lancet"},{"key":"BF03259952_CR43","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/BF03259955","volume":"2","author":"DF Lehmann","year":"1987","unstructured":"Lehmann DF. Primidone crystalluria following overdose: a report of a case and an analysis of the literature. Medical Toxicology 2: 383\u2013387, 1987","journal-title":"Medical Toxicology"},{"key":"BF03259952_CR44","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1016\/S0140-6736(86)91711-3","volume":"1","author":"D Lindhout","year":"1986","unstructured":"Lindhout D, Schmidt D. In-utero exposure to valproate and neural tube defects. Lancet 1: 1392\u20131393, 1986","journal-title":"Lancet"},{"key":"BF03259952_CR45","volume-title":"Comprehensive management of epilepsy in infancy, childhood and adolescence","author":"S Livingstone","year":"1972","unstructured":"Livingstone S. Comprehensive management of epilepsy in infancy, childhood and adolescence, Charles C Thomas, Springfield, 1972"},{"key":"BF03259952_CR46","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1528-1157.1981.tb04094.x","volume":"22","author":"P Loiseau","year":"1981","unstructured":"Loiseau P. Sodium valproate, platelet dysfunction and bleeding. Epilepsia 22: 141\u2013146, 1981","journal-title":"Epilepsia"},{"key":"BF03259952_CR47","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1001\/archneur.1968.00470310083007","volume":"18","author":"RE Lovelace","year":"1968","unstructured":"Lovelace RE, Horowitz SJ. Peripheral neuropathy in long-term diphenylhydantoin therapy. Archives of Neurology 18: 69\u201377, 1968","journal-title":"Archives of Neurology"},{"key":"BF03259952_CR48","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/j.1528-1157.1977.tb04984.x","volume":"18","author":"K Luhdorf","year":"1977","unstructured":"Luhdorf K, Lund M. Phenytoin-induced hyperkinesia. Epilepsia 18: 409\u2013415, 1977","journal-title":"Epilepsia"},{"key":"BF03259952_CR49","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1056\/NEJM197202172860702","volume":"286","author":"G Malherbe","year":"1972","unstructured":"Malherbe G, Burrill KC, Levin SR, Karam JH, Forsham PH. Effect of diphenylhydantoin in insulin secretion in man. New England Journal of Medicine 286: 339\u2013342, 1972","journal-title":"New England Journal of Medicine"},{"key":"BF03259952_CR50","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/j.1528-1157.1982.tb06195.x","volume":"23","author":"C Marescaux","year":"1982","unstructured":"Marescaux C, Warter JM, Micheletti G, Rumbach L, Coquillat G, et al. Stuporous episodes during treatment with sodium valproate: report of seven cases. Epilepsia 23: 297\u2013305, 1982","journal-title":"Epilepsia"},{"key":"BF03259952_CR51","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/j.0954-6820.1976.tb06747.x","volume":"199","author":"L Mosenkilde","year":"1976","unstructured":"Mosenkilde L, Meisen F. Anticonvulsant osteomalacia determined by quantitative analysis of bone changes: population study and possible risk factors. Acta Medica Scandinavica 199: 349\u2013355, 1976","journal-title":"Acta Medica Scandinavica"},{"key":"BF03259952_CR52","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1111\/j.1528-1157.1980.tb04320.x","volume":"21","author":"Y Nakane","year":"1980","unstructured":"Nakane Y, Okuma T, Takahashi R, Sato Y, et al. Multi-institutional study on the teratogenicity and fetal toxicity of antiepileptic drugs: a report of a collaborative study group in Japan. Epilepsia 21: 663\u2013680, 1980","journal-title":"Epilepsia"},{"issue":"1","key":"BF03259952_CR53","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1528-1157.1984.tb05632.x","volume":"25","author":"H Nau","year":"1984","unstructured":"Nau H, Loscher W. Valproic acid and metabolites: pharmacological and toxicological studies. Epilepsia 25 (Suppl. 1): 14\u201322, 1984","journal-title":"Epilepsia"},{"key":"BF03259952_CR54","first-page":"175","volume-title":"Chronic toxicity of antiepileptic drugs","author":"G Offermann","year":"1983","unstructured":"Offermann G. Chronic antiepileptic drug treatment and disorders of mineral metabolism. In Oxley et al. (Eds) Chronic toxicity of antiepileptic drugs, pp. 175\u2013184, Raven Press, New York, 1983"},{"key":"BF03259952_CR55","volume-title":"Chronic toxicity of antiepileptic drugs","author":"J Oxley","year":"1983","unstructured":"Oxley J, Janz D, Meinardi H. Chronic toxicity of antiepileptic drugs, Raven Press, New York, 1983"},{"key":"BF03259952_CR56","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2165\/00003088-198207010-00004","volume":"7","author":"E Perucca","year":"1982","unstructured":"Perucca E. Pharmacokinetic interactions with antiepileptic drugs. Clinical Pharmacokinetics 7: 57\u201384, 1982","journal-title":"Clinical Pharmacokinetics"},{"key":"BF03259952_CR57","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1136\/gut.25.6.673","volume":"25","author":"PR Powell-Jackson","year":"1984","unstructured":"Powell-Jackson PR, Tredger JM, Williams R. Hepatotoxicity to sodium valproate: a review. Gut 25: 673\u2013681, 1984","journal-title":"Gut"},{"key":"BF03259952_CR58","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1111\/j.1528-1157.1983.tb03423.x","volume":"24","author":"T Quijano","year":"1983","unstructured":"Quijano T, del Ser ?, Pareja FB, Munoz-Garcia D, Sanchez AP. Psychological disturbances and folic acid in chronic epileptic outpatients. Epilepsia 24: 588\u2013596, 1983","journal-title":"Epilepsia"},{"key":"BF03259952_CR59","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1001\/archpedi.1961.04020070039007","volume":"101","author":"ML Rallison","year":"1961","unstructured":"Rallison ML, Carlisle JW, Lee RE, Vernier RL, Good RA. Lupus erythematosus and Stevens-Johnson syndrome. American Journal of Diseases of Childhood 101: 725\u2013738, 1961","journal-title":"American Journal of Diseases of Childhood"},{"key":"BF03259952_CR60","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1227\/00006123-198309000-00010","volume":"13","author":"RP Rapp","year":"1983","unstructured":"Rapp RP, Norton JA, Young B, Tibbs PA. Cutaneous reactions in head-injured patients receiving phenytoin for seizure prophylaxis. Neurosurgery 13: 272\u2013275, 1983","journal-title":"Neurosurgery"},{"key":"BF03259952_CR61","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.0954-6820.1971.tb04352.x","volume":"189","author":"A Rausing","year":"1971","unstructured":"Rausing A, Trell E. Malignant lymphogranulomatosis and anticonvulsant therapy. Acta Medica Scandinavica 189: 131\u2013136, 1971","journal-title":"Acta Medica Scandinavica"},{"key":"BF03259952_CR62","doi-asserted-by":"crossref","first-page":"266","DOI":"10.2165\/00003495-197713040-00002","volume":"13","author":"A Richens","year":"1977","unstructured":"Richens A. Interactions with antiepileptic drugs. Drugs 13: 266\u2013275, 1977","journal-title":"Drugs"},{"key":"BF03259952_CR63","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1111\/j.1528-1157.1984.tb03446.x","volume":"25","author":"R Riva","year":"1984","unstructured":"Riva R, Albani F, Ambrosetto G, Contin M, Cortelli P, et al. Diurnal fluctuations in free and total steady-state plasma levels of carbamazepine and correlation with intermittent side effects. Epilepsia 25: 476\u2013481, 1984","journal-title":"Epilepsia"},{"key":"BF03259952_CR64","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0140-6736(82)90908-4","volume":"2","author":"E Robert","year":"1982","unstructured":"Robert E, Guibaud P. Maternal valproic acid and congenital neural tube defects. Lancet 2: 937, 1982","journal-title":"Lancet"},{"key":"BF03259952_CR65","volume-title":"The prognosis of patients with epilepsy","author":"EA Rodin","year":"1968","unstructured":"Rodin EA. The prognosis of patients with epilepsy, Charles C Thomas, Springfield, 1968"},{"key":"BF03259952_CR66","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/1097-0142(195901\/02)12:1<164::AID-CNCR2820120122>3.0.CO;2-Y","volume":"12","author":"SL Saltzstein","year":"1959","unstructured":"Saltzstein SL, Ackermann LV. Lymphadenopathy induced by anticonvulsant drugs and mimicking clinically and pathologically malignant lymphoma. Cancer 12: 164\u2013182, 1959","journal-title":"Cancer"},{"key":"BF03259952_CR67","first-page":"115","volume-title":"Chronic toxicity of antiepileptic drugs","author":"D Schmidt","year":"1983","unstructured":"Schmidt D. Connective tissue disorders induced by antiepileptic drugs. In Oxley et al. (Eds) Chronic toxicity of antiepileptic drugs, pp. 115\u2013124, Raven Press, New York, 1983"},{"key":"BF03259952_CR68","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1001\/archneur.1986.00520030053013","volume":"43","author":"D Schmidt","year":"1986","unstructured":"Schmidt D, Einicke I, Hanel F. The influence of seizure type on the efficacy of plasma concentrations of phenytoin, phenobarbital and carbamazepine. Archives of Neurology 43: 263\u2013265, 1986","journal-title":"Archives of Neurology"},{"key":"BF03259952_CR69","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/j.1528-1157.1983.tb04914.x","volume":"24","author":"D Schmidt","year":"1983","unstructured":"Schmidt D, Kluge W. Fatal toxic epidermal necrolysis following re-exposure to phenytoin: a case report. Epilepsia 24: 440\u2013443, 1983","journal-title":"Epilepsia"},{"key":"BF03259952_CR70","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1001\/archneur.1974.00490400090012","volume":"31","author":"EE Serrano","year":"1974","unstructured":"Serrano EE, Wilder BJ. Intramuscular administration of diphenylhydantoin: histologic follow-up study. Archives of Neurology 31: 276\u2013278, 1974","journal-title":"Archives of Neurology"},{"key":"BF03259952_CR71","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1136\/jnnp.45.7.620","volume":"45","author":"SD Shorvon","year":"1982","unstructured":"Shorvon SD, Reynolds EH. Anticonvulsant peripheral neuropathy: a clinical and electrophysiological study of patients on single drug treatment with phenytoin, carbamazepine or barbiturates. Journal of Neurology, Neurosurgery and Psychiatry 45: 620\u2013626, 1982","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"key":"BF03259952_CR72","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S0022-3476(82)80321-1","volume":"101","author":"FS Silverstein","year":"1982","unstructured":"Silverstein FS, Parrish MA, Johnston MV. Adverse behavioral reactions in children treated with carbamazepine (Tegretol). Journal of Pediatrics 101: 785\u2013787, 1982","journal-title":"Journal of Pediatrics"},{"key":"BF03259952_CR73","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1136\/bmj.2.5527.1434","volume":"2","author":"JR Simpson","year":"1966","unstructured":"Simpson JR. Collagen disease due to carbamazepine (Tegretol). British Medical Journal 2: 1434, 1966","journal-title":"British Medical Journal"},{"key":"BF03259952_CR74","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1542\/peds.57.4.529","volume":"57","author":"BH Singsen","year":"1976","unstructured":"Singsen BH, Fishman L, Hanson V. Antinuclear antibodies and lupus-like syndromes in children receiving anticonvulsants. Pediatrics 57: 529\u2013534, 1976","journal-title":"Pediatrics"},{"key":"BF03259952_CR75","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1136\/bmj.2.6090.804","volume":"2","author":"NJ Smith","year":"1977","unstructured":"Smith NJ, Espir MLE, Baylis PH. Raised plasma arginine vasopressin concentration in carbamazepine-induced water intoxication. British Medical Journal 2: 804, 1977","journal-title":"British Medical Journal"},{"key":"BF03259952_CR76","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1212\/WNL.22.11.1165","volume":"22","author":"GE Solomon","year":"1972","unstructured":"Solomon GE, Hilgartner MW, Kutt H. Coagulation defects caused by diphenylhydantoin. Neurology 22: 1165\u20131171, 1972","journal-title":"Neurology"},{"key":"BF03259952_CR77","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1212\/WNL.32.11.1317","volume":"32","author":"R Stalnikowicz","year":"1982","unstructured":"Stalnikowicz R, Mosseri M, Shalev O. Phenytoin-induced arthritis. Neurology 32: 1317\u20131318, 1982","journal-title":"Neurology"},{"key":"BF03259952_CR78","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1212\/WNL.35.12.1769","volume":"35","author":"N Stilman","year":"1985","unstructured":"Stilman N, Masdeu JC. Incidence of seizures with phenytoin toxicity. Neurology 35: 1769\u20131772, 1985","journal-title":"Neurology"},{"key":"BF03259952_CR79","volume-title":"The falling sickness","author":"O Temkin","year":"1971","unstructured":"Temkin O. The falling sickness, 2nd ed., Johns Hopkins Press, Baltimore, 1971","edition":"2nd"},{"key":"BF03259952_CR80","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1136\/jnnp.46.3.227","volume":"46","author":"PJ Thompson","year":"1983","unstructured":"Thompson PJ, Trimble MR. Anticonvulsant serum levels: relationship to impairments of cognitive functioning. Journal of Neurology, Neurosurgery and Psychiatry 46: 227\u2013233, 1983","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"issue":"1","key":"BF03259952_CR81","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1528-1157.1983.tb04644.x","volume":"24","author":"MR Trimble","year":"1983","unstructured":"Trimble MR, Thompson PJ. Anticonvulsant drugs, cognitive function, and behaviour. Epilepsia 24 (Suppl. 1): 55\u201363, 1983","journal-title":"Epilepsia"},{"key":"BF03259952_CR82","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1111\/j.1528-1157.1975.tb04761.x","volume":"16","author":"AS Troupin","year":"1976","unstructured":"Troupin AS, Ojemann LM. Paradoxical intoxication: a complication of anticonvulsant intoxication. Epilepsia 16: 753\u2013758, 1976","journal-title":"Epilepsia"},{"key":"BF03259952_CR83","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/j.1528-1157.1976.tb04452.x","volume":"17","author":"AS Troupin","year":"1976","unstructured":"Troupin AS, Ojemann LM, Dodrill CB. Mephenytoin: a reappraisal. Epilepsia 17: 403\u2013414, 1976","journal-title":"Epilepsia"},{"key":"BF03259952_CR84","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1212\/WNL.33.9.1136","volume":"33","author":"JM Warter","year":"1983","unstructured":"Warter JM, Brandt C, Marescaux C, Rumbach L, Micheletti G, et al. The renal origin of sodium valproate-induced hyper-ammonemia in fasting humans. Neurology 33: 1136\u20131140, 1983","journal-title":"Neurology"},{"key":"BF03259952_CR85","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1136\/adc.58.7.543","volume":"58","author":"LHP Williams","year":"1983","unstructured":"Williams LHP, Reynolds RP, Emery JL. Pancreatitis during sodium valproate treatment. Archives of Disease in Childhood 58: 543\u2013544, 1983","journal-title":"Archives of Disease in Childhood"},{"key":"BF03259952_CR86","volume-title":"Antiepileptic drugs","year":"1982","unstructured":"Woodbury DM, Penry JK, Pippenger CE (Eds). Antiepileptic drugs, 2nd ed., Raven Press, New York, 1982","edition":"2nd"},{"key":"BF03259952_CR87","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1002\/hep.1840020520","volume":"2","author":"ES Zafrani","year":"1982","unstructured":"Zafrani ES, Berthelot P. Sodium valproate in the induction of unusual hepatotoxicity. Hepatology 2: 648\u2013649, 1982","journal-title":"Hepatology"},{"key":"BF03259952_CR88","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1002\/hep.1840020513","volume":"2","author":"HJ Zimmerman","year":"1982","unstructured":"Zimmerman HJ, Ishak KG. Valproate-induced hepatic injury: analysis of 23 fatal cases. Hepatology 2: 591\u2013597, 1982","journal-title":"Hepatology"}],"container-title":["Medical Toxicology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03259952.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03259952\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03259952","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T14:33:05Z","timestamp":1643725985000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03259952"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1987,10]]},"references-count":88,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1987,10]]}},"alternative-id":["BF03259952"],"URL":"https:\/\/doi.org\/10.1007\/bf03259952","relation":{},"ISSN":["0112-5966"],"issn-type":[{"value":"0112-5966","type":"print"}],"subject":[],"published":{"date-parts":[[1987,10]]}}}